Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Luminal Breast Cancer Cryoablation [NA]
The clinical trial update indicates a luminal breast cancer cryoablation study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Impact of Regional Anesthesia on Chronic Post-operative Pain
A clinical trial assessing the effect of regional anesthesia on chronic post-operative pain in breast cancer patients is currently enrolling…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer [Phase 2]
A Phase 2 clinical trial is evaluating adding stereotactic body radiation therapy to standard drug therapy for breast cancer, including olig…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer [NA]
A clinical trial at MD Anderson is evaluating a decision-making tool to assist patients with newly diagnosed breast cancer in deciding about…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study of capecitabine given on a 7/7 schedule in combination with neratinib for metastatic …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib [Phase 3]
Phase 3 rollover study of Olaparib for patients who have completed a prior oncology trial is active but not recruiting. The trial is sponsor…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Study of PF-07248144 in Advanced or Metastatic Solid Tumors [Phase 2]
Pfizer is conducting a Phase 2 study of PF-07248144 in locally advanced or metastatic ER+ HER2- breast cancer, locally advanced or metastati…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA) [Phase 1]
Phase Ib study investigating alpelisib in combination with pembrolizumab in metastatic breast cancer or melanoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Breast Cancer Evolution During Neoadjuvant Systemic Therapy
Update on a breast cancer neoadjuvant systemic therapy trial, currently recruiting and covering ER-positive, HER2-positive, and triple-negat…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Effects of Instrument-Assisted Constant-Speed Injection Versus Manual Injection on Pain From Large-Volume Subcutaneous Injection of Pertuzumab and Trastuzumab in Breast Cancer: A Randomized, Self-Controlled Study [NA]
A randomized, self-controlled study protocol comparing instrument-assisted constant-speed injection to manual injection for large-volume sub…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Evaluating Cascade Communication Methods
A completed University of Pennsylvania clinical trial evaluating cascade communication methods for individuals with BRCA1 or BRCA2 mutations…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Impact of Prehabilitation and Comprehensive Follow-up in Women With Breast Cancer [NA]
A clinical trial investigating prehabilitation and comprehensive follow-up in women with breast cancer is currently recruiting.
-
CLINICAL_TRIALS withdrawal · 2026-04-16Clinical Trial Update: Molecular Surveillance In Early Breast Cancer Using The Tumor-Informed ctDNA Assay Myriad Genetics Precise MRD Test; A Prospective Observational Multicenter Study (The MRD Molecular Surveillance Study)
A multicenter observational study evaluating a tumor-informed ctDNA MRD assay for molecular surveillance in early breast cancer has been wit…
-
FDA approval · 2026-04-15FDA Approved: ONTRUZANT — Supplemental Application (Organon LLC)
FDA approved a supplemental application for ONTRUZANT (trastuzumab) submitted by Organon LLC. The approval encompasses labeling updates rela…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF [Phase 1]
Phase 1 study to evaluate serial PET/CT imaging with the novel radiotracer [18F] Fluorthanatrace for cancer imaging; currently recruiting ac…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: GCC 1366: Anti-Proliferative Response to NeoAdjuvant AIs in Overweight and Obese Patients [NA]
The GCC 1366 trial evaluating anti-proliferative response to neoadjuvant aromatase inhibitors in overweight and obese breast cancer patients…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer [Phase 1, Phase 2]
This update reports the completion of a Phase 1/2 clinical trial evaluating ARV-471 alone and in combination with palbociclib (Ibrance) in p…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors [NA]
This completed clinical trial evaluated the effectiveness and implementation of an electronic health record tool to assess heart health amon…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread [Phase 1, Phase 2]
A Phase 1/2 trial evaluating the dose of Zongertinib used alone or with other therapies in HER2-positive metastatic cancers, including breas…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer Treatment [Phase 2]
A Phase 2 clinical trial update on electroacupuncture to reduce chronic pain after breast cancer treatment, sponsored by MD Anderson, curren…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: 18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in Patients [Phase 1]
Phase 1 trial evaluating 18F-Fluoroazomycin Arabinoside PET-CT for diagnosing solid tumors, including breast and colorectal cancers, with ac…
-
CLINICAL_TRIALS withdrawal · 2026-04-15Clinical Trial Update: Study to Determine the Safety and Efficacy of Ribociclib in Combination With Hormone Therapy and Hypofractionated Radiotherapy in Breast Cancer, With Positive Hormone Receptors and Negative HER2 Status, in Newly Diagnosed, Not Immediately Operable Elderly Patient (CALHYS) [Phase 1, Phase 2]
A Phase 1/2 trial CALHYS evaluating ribociclib in combination with hormone therapy and hypofractionated radiotherapy for elderly patients wi…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Study of XB010 in Subjects With Solid Tumors [Phase 1]
A Phase 1 trial evaluating XB010 in locally advanced or metastatic solid tumors is currently recruiting across multiple indications.
-
CLINICAL_TRIALS other · 2026-04-15Clinical Trial Update: Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer [Phase 2]
A Phase 2 study of Zelenectide Pevedotin in advanced breast cancer is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Selumetinib and Olaparib in Solid Tumors [Phase 1]
Phase 1 trial evaluating the combination of selumetinib and olaparib in various solid tumors; the study is currently active but not recruiti…